Cardiol Therapeutics (CRDL) Amortizatization of Intangibles (2020 - 2024)

Cardiol Therapeutics' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $123252.7 for Q3 2024.

• Quarterly Amortizatization of Intangibles rose 682.69% year-over-year to $123252.7 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $170101.9 (up 168.87% YoY) and the FY2021 annual result came in at $67382.5, up 6.9% from the prior year.
• Amortizatization of Intangibles was $123252.7 for Q3 2024 at Cardiol Therapeutics, up from $15435.1 in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $123252.7 in Q3 2024 and bottomed at $15435.1 in Q2 2024.
• A 5-year average of $23886.5 and a median of $16375.8 in 2022 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles dropped 6.31% — and 2024, when it surged 682.69%.
• Cardiol Therapeutics' Amortizatization of Intangibles stood at $16193.3 in 2020, then grew by 3.43% to $16748.1 in 2021, then declined by 3.35% to $16186.8 in 2022, then declined by 2.71% to $15747.3 in 2023, then jumped by 682.69% to $123252.7 in 2024.
• Business Quant data shows CRDL's Amortizatization of Intangibles at $123252.7 in Q3 2024, $15435.1 in Q2 2024, and $15666.8 in Q1 2024.